Trial Profile
Evaluation of Naltrexone as a Treatment for Self-Injurious Behavior
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Self-injurious behaviour
- Focus Therapeutic Use
- Acronyms NTX-SIB
- 31 Oct 2017 Planned End Date changed from 1 Sep 2018 to 4 Jan 2017.
- 31 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 30 Jun 2015.
- 31 Oct 2017 Planned initiation date changed from 1 Sep 2016 to 22 Feb 2014.